Creative Edge Nutrition, Inc. (OTCMKTS:FITX) Wobbles Along

Yesterday marked another green session for Creative Edge Nutrition, Inc. (OTCMKTS:FITX), even if the move was a humble one. The ticker closed 2% up on volume comparable to its monthly average and stopped at $0.038 per share.

To the disappointment of FITX hopeful investors, the company is still not part of the Health Canada MMPR licensee list. As a matter of fact, the list has not been updated with any new entries in quite a while. Yesterday another marijuana license applicant made headlines after filing a motion in a federal court against Health Canada and health minister Rona Ambrose in particular. The company in question is called New Age Medical Solutions, Inc. (NAMS) and is one of the many that run the licensing race with Health Canada.

NAMS claims that its license was denied because according to Health Canada the company had not hired an ‘acceptable’ QA specialist. The court filing argues that the decision to deny NAMS a license was ‘highly prejudicial’.

FITX are part of the queue of nearly 300 companies who are stalled by the inability of unwillingness of Health Canada to license any more entities. Creative Edge are facing another issue as well. The pre-license inspection report, which the company published last week, states that the growing pod displayed before Health Canada inspectors was a scaled-down, prototype version. The report concluded that since FITX did not have the full-scale growing pods at the time, it was impossible to assess whether they meet requirements and the facility will need to be re-inspected to assess the security measures for the final, full-sized pods. The company has not announced a date for such a re-inspection. The company’s official Facebook page reassures investors that “pods are not an issue”.

While shareholders are watching the charts, FITX CEO Bill Chabaan is traveling the globe. After meeting with Ukrainian officials a month ago, Mr. Chabaan made a more recent trip to Tanzania of all places, on what was announced as a formal business trip.

FITX, along with the entire marijuana sector of the OTC, is trading deep in the red in today’s early session.

You may also like...